Literature DB >> 24597524

Robot-assisted arm training in patients with Parkinson's disease: a pilot study.

Alessandro Picelli, Stefano Tamburin, Michele Passuello, Andreas Waldner, Nicola Smania1.   

Abstract

BACKGROUND: Despite the growing diffusion of robotic devices in neurorehabilitation, no previous study investigated the effects of robotic training on arm impairment due to Parkinson's disease. The aim of this pilot study was to evaluate whether robot-assisted arm training might improve upper limb function in patients with Parkinson's disease.
FINDINGS: Ten patients with Parkinson's disease (Hoehn and Yahr stage 2.5-3) received ten, 45-minute, treatment sessions, five days a week, for two consecutive weeks. Robot-assisted arm training was performed with the Bi-Manu-Track (Reha-Stim, Berlin, Germany) that provides a computer-controlled, repetitive, bilateral, mirror-like practice of forearm pronation/supination and wrist extension/flexion. Patients were trained according to the following modalities: passive-passive (both arms moved by the machine) and active-active (both arms actively moving against resistance). The dominant upper limb was evaluated before and immediately after treatment as well as at two weeks of follow-up. Outcomes were the nine-hole peg test, the Fugl-Meyer assessment (upper limb section) and the Unified Parkinson's Disease Rating Scale. After treatment, a significant improvement was found in the nine-hole peg test (P = 0.007) as well as in the upper limb section of the Fugl-Meyer assessment (P = 0.012). Findings were confirmed at the 2-week follow-up evaluation only for the nine-hole peg test (P = 0.007). No significant improvement was found in the Unified Parkinson's Disease Rating Scale at both post-treatment and follow-up evaluations.
CONCLUSIONS: Our findings support the hypothesis that robot-assisted arm training might be a promising tool in order to improve upper limb function in patients with Parkinson's disease.

Entities:  

Mesh:

Year:  2014        PMID: 24597524      PMCID: PMC3973978          DOI: 10.1186/1743-0003-11-28

Source DB:  PubMed          Journal:  J Neuroeng Rehabil        ISSN: 1743-0003            Impact factor:   4.262


Introduction

Parkinson’s disease (PD) is an idiopathic neurodegenerative disorder due to a progressive loss of dopaminergic neurons in the substantia nigra pars compacta [1]. Typical features of PD are bradykinesia (slowed movement), hypokinesia (poverty of movement), rigidity and resting tremor [1,2]. Even if impaired manual dexterity with progressive limitations in reaching, grasping and fine motor tasks has been described in PD, to date evidence base for upper limb intervention strategies in parkinsonian patients is lacking [3]. Robotic arm training (RAT) was found to effectively improve upper limb function in patients with neurological disorders, such as stroke [4]. As to PD, forced use, task-specific, intensive, training programs based on robotic devices were found to effectively improve lower limb function [5-10]. Despite the growing diffusion of robotic devices in neurorehabilitation, to date no previous study investigated the effects of robotic training on arm impairment due to PD. The aim of this pilot study was to evaluate whether RAT might improve upper limb function in patients with PD.

Methods

This study was performed in the Neurorehabilitation Unit of the Azienda Ospedaliera-Universitaria Integrata of Verona, Italy. Inclusion criteria: confirmed diagnosis of idiopathic PD according to the UK Brain Bank Criteria [11]; Hoehn and Yahr (H&Y) stage of 2.5 or 3 determined in the "on" phase [12]; Mini Mental State Examination score >24 [13]. Exclusion criteria: severe dyskinesias or "on-off" fluctuations; change of PD medication during the study; deficits of somatic sensation involving the upper limbs; other neurological or orthopedic conditions involving the upper limbs. All participants were outpatients and gave their informed written consent for participation in the study, which was carried out according to the Declaration of Helsinki and was approved by the Ethics Committee of the Department of Neurological and Movement Sciences of Verona University. During the study, participants were instructed to take their normal PD medications: they were tested and trained during the on phase (1 to 2.5 hours after taking morning dose). Participants did not perform any type of rehabilitation in the three months before the study, nor undergo any form of training other than that scheduled in the study protocol.

Treatment procedures

Each patient underwent a training program consisting of ten, 45-minute sessions (including rest periods), five days a week (from Monday to Friday) for two consecutive weeks. Robot-assisted arm training was performed with the Bi-Manu-Track (Reha-Stim, Berlin, Germany) that provides a computer-controlled, repetitive, bilateral, mirror-like practice of forearm pronation/supination and wrist extension/flexion according to three modalities: passive-passive (both arms moved by the machine), active-passive (one arm driving the other), and active-active (both arms actively moving against resistance) [14]. As shown in Figure  1, patients sat at a height-adjustable table with their elbow bent at 90°, putting their forearms into an arm trough and grasping a handle (written informed consent for the publication of this image was obtained). Each training session consisted of two parts with a 5-minute rest between them. First we trained forearm pronation/supination for 20 minutes: 10 minutes of passive-passive mode (100 repetitions) followed by 10 minutes of active-active mode (100 repetitions). Then we trained wrist extension/flexion for 20 minutes: 10 minutes of passive-passive mode (100 repetitions) followed by 10 minutes of active-active mode (100 repetitions). Amplitude and resistance were set individually.
Figure 1

Robot-assisted arm training.

Robot-assisted arm training.

Testing procedures

Patients were evaluated before (T0), immediately after treatment (T1) (primary endpoint) and at two weeks of follow-up (T2). The same rater evaluated all patients.

Outcome measures

The nine-hole peg test (NHPT) was used to assess dominant hand dexterity. We required patients to take 9 pegs from a container placing them into 9 holes on a board and vice versa as quickly as possible. Score was the time taken to complete the test activity [15]. The Fugl-Meyer assessment (FM) was used to evaluate dominant upper limb motor ability to perform selective movements. The FM upper limb section allows a maximum score of 66, with sub-scores of 36 for the upper arm, 10 for the wrist, 14 for the hand, and 6 for coordination and speed of movement [16,17]. The Unified Parkinson’s Disease Rating Scale (UPDRS) was used to measure disease severity in PD. It has three subscales: I–mentation, behavior, and mood (range 0–16); II–activities of daily living (range 0–52); III–motor examination (range 0–108). Total score is the sum of these subscales (range 0–176) [18,19].

Statistical analysis

Statistical analysis was carried out with SPSS 21.0 (SPSS Inc, Chicago, IL). The Friedman test was used to analyze overall changes in performance between the different evaluation sessions. In the presence of significant main effects, the Wilcoxon signed ranks test was used on the T1 vs. T0, T2 vs. T0 and T2 vs. T1 comparisons to determine any significant difference. Descriptive analysis was used to evaluate the effect size measures (Cohen’s d calculation) and the 95% confidence intervals [20]. The level for significance was P < 0.05. The Bonferroni correction was used when investigating multiple comparisons (P < 0.016) [21].

Results

Ten right-handed subjects (7 males and 3 females; mean age 70.7 years) presenting with idiopathic PD (mean duration 7.1 years) were recruited from among 18 outpatients consecutively admitted to our Neurorehabilitation Unit from April to October 2012. No dropout was observed. No adverse event occurred during the study. Row data (medians and interquartile ranges) of patients’ performance at T0, T1 and T2 evaluations are reported in Table  1.
Table 1

Row data of patients’ performance in all outcome measures

OutcomesBefore treatment
After treatment
Follow-up
Median (IQR)Median (IQR)Median (IQR)
Nine-hole peg test (s)
16.20 (15.80 to 18.18)
13.80 (13.06 to 14.92)
13.80 (13.08 to 15.13)
Fugl-Meyer assessment (0–66)
60.00 (57.25 to 62.00)
65.00 (62.50 to 65.75)
63.50 (62.00 to 65.75)
UPDRS motor examination (0–108)
16.00 (12.25 to 18.50)
14.50 (13.25 to 15.75)
15.00 (13.25 to 16.00)
UPDRS total (0–176)34.50 (25.27 to 37.75)30.00 (24.00 to 34.00)27.50 (23.00 to 34.00)

Abbreviations: IQR Interquartile range, s seconds, UPDRS Unified Parkinson’s Disease Rating Scale.

Row data of patients’ performance in all outcome measures Abbreviations: IQR Interquartile range, s seconds, UPDRS Unified Parkinson’s Disease Rating Scale. As to the NHPT, a significant overall change was found between the three time points (P = 0.007; χ2 = 9.800). A significant difference was found at both T1 vs. T0 (P = 0.007) and T2 vs. T0 (P = 0.007) comparisons. As to the FM, a significant overall change was found between the three time points (P = 0.003; χ2 = 11.400). A significant difference was found only at T1 vs. T0 (P = 0.012) comparison. As to the UPDRS, no significant overall change was found between the three time points (P = 0.062; χ2 = 5.568) at the Friedman test. Treatment effects in all outcome measures are reported in Table  2.
Table 2

Treatment effects in all outcome measures

OutcomesComparisons
95% Confidence interval
Wilcoxon signed ranks test
(Effect size)
T1 vs. T0
T2 vs. T0
T2 vs. T1
T1 vs. T0
T2 vs. T0
T2 vs. T1
P value (Z) P value (Z) P value (Z)( r )( r )( r )
Nine-hole peg test (s)
0.007 (-2.701)*
0.007 (-2.701)*
0.359 (-0.918)
1.90 to 4.78 (-0.60)
1.73 to 4.34 (-0.53)
-1.07 to 0.47 (0.08)
Fugl-Meyer assessment (0–66)
0.012 (-2.527)*
0.018 (-2.371)
0.606 (-0.516)
-6.31 to -1.28 (0.45)
-5.53 to -1.26 (0.41)
-1.62 to 2.42 (-0.07)
UPDRS motor examination (0–108)
0.097 (-1.658)
0.174 (-1.358)
0.334 (-0.966)
-0.34 to 2.54 (-0.14)
-0.40 to 2.00 (-0.11)
-1.05 to 0.45 (0.04)
UPDRS total (0–176)0.046 (-1.995)0.037 (-2.082)0.813 (-0.214)0.26 to 6.73 (-0.20)0.54 to 6.65 (-0.20)-1.30 to 1.50 (-0.01)

Abbreviations:UPDRS Unified Parkinson’s Disease Rating Scale.

* = statistically significant after Bonferroni correction (P < 0.016).

Treatment effects in all outcome measures Abbreviations:UPDRS Unified Parkinson’s Disease Rating Scale. * = statistically significant after Bonferroni correction (P < 0.016).

Discussion

Our results show that ten, 45-minute sessions of RAT may improve fine and gross motor function of the dominant upper limb in patients with PD (H&Y 2.5-3). As measured by the NHPT, improvements of fine motor function were maintained also at the follow-up examination. Conversely, no significant change was found in the UPDRS. In people with PD, altered upper limb function generally manifests as impaired timing and force modulation, progressively affecting the quality of hand movement [3]. Even if intensive, task-specific, practice has been proposed to reduce arm impairment due to PD, the most effective rehabilitative approach in order to best facilitate upper limb skill learning has not yet been defined [3]. Our preliminary findings about the role of RAT in PD are in keeping with those evidences about the effective use of robotic devices provide task-specific, intensive, training programs in patients with progressive lower limb functional impairment due to PD [5-10]. Furthermore, our findings are in line with those of Lee and colleagues, which examined the effects of constraint-induced movement therapy in twenty patients with PD (H&Y 2–3), observing significant improvements of fine and gross motor performance of the upper limb after twenty, 3-hour, treatment sessions [22]. In order to understand why RAT showed to improve upper limb function in PD, we hypothesize that several repetitions of rhythmic arm movements could act as an external proprioceptive cue, by reinforcing the neuronal circuits that contribute to the upper limb movements. In particular, RAT provides an external rhythm that could improve motor output bypassing the deficient internal motor generation system (including the supplementary motor area and basal ganglia) that would support the generation on actions based on intention and internal reference frame [22]. In addition, it is plausible that the strengthening effect of RAT would play a role. In line with this issue, a previous case series study by Combs and colleagues, described a significantly reduction of disability as well as an improvement of quality of life after a training program based on 24 to 36 boxing sessions in 6 patients with PD (H&Y 1–4) [23]. Unfortunately, the Authors did not evaluate upper limbs function before and after treatment [23]. Thus, we cannot directly compare their data with ours. This pilot study was limited by the lack of a control group and the small sample size. Furthermore there is no long-term follow-up evaluation and no assessment of activities of daily living.

Conclusions

Our preliminary findings support the hypothesis that RAT might be a promising tool in order to improve upper limb function in patients with PD. However, there is the possibility that changes observed in this pilot study might be due to a placebo effect. Furthermore, it would be useful to evaluate RAT not only in terms of effectiveness but also in terms of costs and time taken to prepare the treatment setting. On these bases, future, properly sized, randomized controlled trials dealing with RAT compared to conventional/non-robotic rehabilitation are needed in order to further validate our results.

Abbreviations

PD: Parkinson’s disease; RAT: Robotic arm training; H&Y: Hoehn and Yahr; NHPT: Nine-hole peg test; FM: Fugl-Meyer assessment; UPDRS: Unified Parkinson’s Disease Rating Scale.

Competing interests

The authors declare that they have no competing interest.

Authors’ contributions

AP conceived the study, made substantial contribution to its design, performed the statistical analysis and drafted the manuscript. ST participated in the design of the study and helped to draft the manuscript. MP carried out the acquisition of data. AW revised critically the manuscript for important intellectual content. NS coordinated the study and revised critically the manuscript for important intellectual content. All authors read and approved the final manuscript.
  17 in total

1.  The post-stroke hemiplegic patient. 1. a method for evaluation of physical performance.

Authors:  A R Fugl-Meyer; L Jääskö; I Leyman; S Olsson; S Steglind
Journal:  Scand J Rehabil Med       Date:  1975

2.  Modified constraint-induced movement therapy improves fine and gross motor performance of the upper limb in Parkinson disease.

Authors:  Kyoung-Suk Lee; Wan-Hee Lee; Sujin Hwang
Journal:  Am J Phys Med Rehabil       Date:  2011-05       Impact factor: 2.159

3.  Parkinsonism: onset, progression and mortality.

Authors:  M M Hoehn; M D Yahr
Journal:  Neurology       Date:  1967-05       Impact factor: 9.910

4.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

Authors:  A J Hughes; S E Daniel; L Kilford; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-03       Impact factor: 10.154

5.  Boxing training for patients with Parkinson disease: a case series.

Authors:  Stephanie A Combs; M Dyer Diehl; William H Staples; Lindsay Conn; Kendra Davis; Nicole Lewis; Katie Schaneman
Journal:  Phys Ther       Date:  2010-11-18

6.  Robot-assisted gait training in patients with Parkinson disease: a randomized controlled trial.

Authors:  Alessandro Picelli; Camilla Melotti; Francesca Origano; Andreas Waldner; Antonio Fiaschi; Valter Santilli; Nicola Smania
Journal:  Neurorehabil Neural Repair       Date:  2012-01-18       Impact factor: 3.919

Review 7.  Motor learning in Parkinson's disease: limitations and potential for rehabilitation.

Authors:  Alice Nieuwboer; Lynn Rochester; Liesbeth Müncks; Stephan P Swinnen
Journal:  Parkinsonism Relat Disord       Date:  2009-12       Impact factor: 4.891

8.  Reduction of freezing of gait in Parkinson's disease by repetitive robot-assisted treadmill training: a pilot study.

Authors:  Albert C Lo; Victoria C Chang; Milena A Gianfrancesco; Joseph H Friedman; Tara S Patterson; Douglas F Benedicto
Journal:  J Neuroeng Rehabil       Date:  2010-10-14       Impact factor: 4.262

9.  The clinically important difference on the unified Parkinson's disease rating scale.

Authors:  Lisa M Shulman; Ann L Gruber-Baldini; Karen E Anderson; Paul S Fishman; Stephen G Reich; William J Weiner
Journal:  Arch Neurol       Date:  2010-01

Review 10.  Electromechanical and robot-assisted arm training for improving generic activities of daily living, arm function, and arm muscle strength after stroke.

Authors:  Jan Mehrholz; Anja Hädrich; Thomas Platz; Joachim Kugler; Marcus Pohl
Journal:  Cochrane Database Syst Rev       Date:  2012-06-13
View more
  10 in total

1.  Improving Upper Extremity Bradykinesia in Parkinson's Disease: A Randomized Clinical Trial on the Use of Gravity-Supporting Exoskeletons.

Authors:  Loredana Raciti; Loris Pignolo; Valentina Perini; Massimo Pullia; Bruno Porcari; Desiree Latella; Marco Isgrò; Antonino Naro; Rocco Salvatore Calabrò
Journal:  J Clin Med       Date:  2022-05-01       Impact factor: 4.964

2.  Design and Development of a Smart Exercise Bike for Motor Rehabilitation in Individuals with Parkinson's Disease.

Authors:  Hassan Mohammadi-Abdar; Angela L Ridgel; Fred M Discenzo; Kenneth A Loparo
Journal:  IEEE ASME Trans Mechatron       Date:  2015-12-11       Impact factor: 5.303

Review 3.  Proprioceptive rehabilitation of upper limb dysfunction in movement disorders: a clinical perspective.

Authors:  Giovanni Abbruzzese; Carlo Trompetto; Laura Mori; Elisa Pelosin
Journal:  Front Hum Neurosci       Date:  2014-11-25       Impact factor: 3.169

4.  Support System to Improve Reading Activity in Parkinson's Disease and Essential Tremor Patients.

Authors:  Franklin Parrales Bravo; Alberto A Del Barrio García; Mercedes Gallego de la Sacristana; Lydia López Manzanares; José Vivancos; José Luis Ayala Rodrigo
Journal:  Sensors (Basel)       Date:  2017-05-03       Impact factor: 3.576

5.  Parameters of Surface Electromyogram Suggest That Dry Immersion Relieves Motor Symptoms in Patients With Parkinsonism.

Authors:  German G Miroshnichenko; Alexander Yu Meigal; Irina V Saenko; Liudmila I Gerasimova-Meigal; Liudmila A Chernikova; Natalia S Subbotina; Saara M Rissanen; Pasi A Karjalainen
Journal:  Front Neurosci       Date:  2018-09-26       Impact factor: 4.677

6.  Editorial: New Advances in Neurorehabilitation.

Authors:  Stefano Tamburin; Nicola Smania; Leopold Saltuari; Volker Hoemberg; Giorgio Sandrini
Journal:  Front Neurol       Date:  2019-10-17       Impact factor: 4.003

7.  Rehabilitation of older people with Parkinson's disease: an innovative protocol for RCT study to evaluate the potential of robotic-based technologies.

Authors:  Roberta Bevilacqua; Elvira Maranesi; Mirko Di Rosa; Riccardo Luzi; Elisa Casoni; Nadia Rinaldi; Renato Baldoni; Fabrizia Lattanzio; Valentina Di Donna; Giuseppe Pelliccioni; Giovanni Renato Riccardi
Journal:  BMC Neurol       Date:  2020-05-13       Impact factor: 2.474

Review 8.  Living with Parkinson's and the Emerging Role of Occupational Therapy.

Authors:  Jelka Jansa; Ana Aragon
Journal:  Parkinsons Dis       Date:  2015-10-01

Review 9.  Pathophysiology of Motor Dysfunction in Parkinson's Disease as the Rationale for Drug Treatment and Rehabilitation.

Authors:  Francesca Magrinelli; Alessandro Picelli; Pierluigi Tocco; Angela Federico; Laura Roncari; Nicola Smania; Giampietro Zanette; Stefano Tamburin
Journal:  Parkinsons Dis       Date:  2016-06-06

10.  Acceptability and Preliminary Results of Technology-Assisted Balance Training in Parkinson's Disease.

Authors:  Elvira Maranesi; Valentina Di Donna; Giuseppe Pelliccioni; Valentina Cameriere; Elisa Casoni; Renato Baldoni; Marco Benadduci; Nadia Rinaldi; Lorenzo Fantechi; Cinzia Giammarchi; Riccardo Luzi; Paolo Pelliccioni; Mirko Di Rosa; Pietro Scendoni; Giovanni Renato Riccardi; Roberta Bevilacqua
Journal:  Int J Environ Res Public Health       Date:  2022-02-24       Impact factor: 3.390

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.